Related Experiment Video
Updated: Aug 8, 2026

Determination of Protein Expression Level in Cultured Cells by Immunocytochemistry on Paraffin-embedded Cell Blocks
Published on: May 20, 2018
Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded
M A Vasef1, L J Medeiros, L S Yospur
1Division of Pathology, City of Hope National Medical Center, Duarte, CA 91010, USA.
Insights
Cyclin D1 protein is expressed in about 26% of plasma cell neoplasms, including multiple myeloma. This expression correlates with tumor differentiation and stage, suggesting mechanisms beyond the t(11;14) translocation.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Plasma cell neoplasms are a group of hematologic malignancies.
- Cyclin D1 is a cell cycle regulatory protein.
- The t(11;14) translocation is a known genetic abnormality in some plasma cell neoplasms.
Purpose of the Study:
- To investigate the expression of cyclin D1 protein in various plasma cell neoplasms.
- To determine the correlation between cyclin D1 expression and clinicopathologic features.
- To explore the relationship between cyclin D1 expression and the t(11;14) translocation.
Main Methods:
- Immunohistochemistry was used to detect cyclin D1 protein in 69 plasma cell neoplasms (54 multiple myelomas, 3 plasma cell leukemias, 12 plasmacytomas).
- Tissue sections were routinely fixed and paraffin-embedded.
- Polymerase chain reaction (PCR) was used to analyze for the t(11;14) translocation in a subset of cases.
Main Results:
- Cyclin D1 protein was expressed in 18 (26%) of 69 cases.
- Expression was observed in 16 (30%) of multiple myelomas and 2 (17%) of plasmacytomas.
- Cyclin D1 expression correlated with intermediate/immature cytologic features and histologic Stage III in multiple myeloma.
- Only one multiple myeloma case harbored the t(11;14) translocation and expressed cyclin D1.
Conclusions:
- Cyclin D1 protein expression is found in approximately one-quarter of plasma cell neoplasms.
- Cyclin D1 expression is associated with specific cytologic and histologic characteristics of multiple myeloma.
- The frequent cyclin D1 expression, relative to the incidence of t(11;14), suggests alternative regulatory mechanisms are involved.
Abstract:
In this study, we analyzed 69 plasma cell neoplasms, including 54 multiple myelomas (MMs), 3 cases of plasma cell leukemia, and 12 plasmacytomas, for expression of cyclin D1 protein using an immuno-histochemical method applied to routinely fixed, paraffin-embedded tissue sections. Cyclin D1 was expressed in 18 (26%) of 69 plasma cell neoplasms, including 16 (30%) of 54 MMs and 2 (17%) of 12 plasmacytomas. Three cases of plasma cell leukemia were negative. Cyclin D1 expression correlated with the cytologic differentiation and histologic stage of MM. Twelve (75%) of 16 MMs had intermediate or immature cytologic features and were histologic Stage III. With use of a polymerase chain reaction assay, we also analyzed six cases (three cyclin D1 positive, three cyclin D1 negative) for the t(11;14); one MM carried the t(11;14) and expressed cyclin D1 protein. We conclude that cyclin D1 expression occurs in approximately one-quarter of plasma cell neoplasms and correlates with the degree of cytologic differentiation and histologic stage. The relatively high frequency of cyclin D1 expression, compared with the less than 5% incidence of the t(11;14) detected by conventional cytogenetics reported in the literature, suggests that upregulation of cyclin D1 protein might be the result of mechanisms other than the t(11;14).
Related Concept Videos
Positive Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation

